CJC-1295-Without-DAC-+-Ipamorelin-10mg

Product Specifications

Form: Combined lyophilized peptide powder

Total Strength: Add the product-specific total strength

Component Ratio: Add the verified CJC-1295 Without DAC to Ipamorelin ratio

Product Classification: Synthetic dual-peptide receptor research blend

Component One: CJC-1295 Without DAC, also known as Modified GRF (1-29)

CJC-1295 Without DAC Peptide Length: 29 amino-acid residues

CJC-1295 Without DAC Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

CJC-1295 Without DAC Classification: Synthetic tetrasubstituted and amidated GHRH (1-29) analog

CJC-1295 Without DAC Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ for the amidated free peptide form

CJC-1295 Without DAC Molecular Weight: Approximately 3368.0 g/mol for the amidated free peptide form

CJC-1295 Without DAC CAS Number: 863288-34-0

Component Two: Ipamorelin

Ipamorelin Peptide Length: 5 amino-acid residues

Ipamorelin Modified Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Ipamorelin Classification: Synthetic amidated growth hormone secretagogue receptor research peptide

Ipamorelin Molecular Formula: C₃₈H₄₉N₉O₅ for the free peptide form

Ipamorelin Molecular Weight: Approximately 711.86 g/mol for the free peptide form

Ipamorelin CAS Number: 170851-70-4

Molecular Formula: No single molecular formula applies to the complete blend

Molecular Weight: Each component has an independent molecular weight

CAS Number: No single CAS number applies to the combined formulation

Purity: Each component should meet the stated purity specification where confirmed through batch-specific HPLC analysis

Appearance: White to off-white lyophilized powder

Intended Use: Laboratory research and analytical applications only

Research Applications

• Analytical separation and characterization using HPLC, UPLC, and LC-MS workflows
• In vitro investigation of GHRH and growth hormone secretagogue receptor-associated systems
• Comparative evaluation of individual peptide components and the combined formulation
• Study of ligand-receptor interactions under controlled biochemical assay conditions
• Structure-activity analysis of modified GHRH-related and pentapeptide sequences
• Assessment of component identity, concentration, purity, and blend ratio
• Stability profiling under defined temperature, pH, buffer, and storage conditions

Quality Documentation

A batch-specific Certificate of Analysis and applicable analytical documentation should be available for each lot. Documentation should confirm both peptide identities, complete modified sequences, individual strengths, blend ratio, purity results, molecular weights, amidation status, salt forms, formulation details, and batch identification. CJC-1295 Without DAC should be clearly distinguished from CJC-1295 with DAC in all product and analytical records.

For Laboratory Research Use Only

This product is intended exclusively for controlled laboratory and in vitro research. Not for human or veterinary use. Not for diagnostic, therapeutic, clinical, cosmetic, personal-care, or household applications.